| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000224429.3 |
Selumetinib |
Esophageal cancer |
0.046777601 |
Resistant |
| ENSG00000224429.3 |
Selumetinib |
Bladder urothelial carcinoma |
0.009363131 |
Sensitive |
| ENSG00000224429.3 |
Selumetinib |
Colon adenocarcinoma |
0.014095367 |
Sensitive |
